Charlottesville, VA, United States of America

Brant E Isakson

This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: University of Virginia Patent Foundation. Active years: 2017-2022.

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Brant E Isakson: Innovator in Blood Pressure Regulation and Leukocyte Adhesion

Introduction

Brant E Isakson is a prominent inventor based in Charlottesville, VA, known for his significant contributions to the fields of vascular biology and pharmacology. With a total of five patents to his name, Isakson's work focuses on understanding and regulating critical physiological processes.

Latest Patents

Isakson's latest patents include innovative compositions and methods for regulating blood pressure. His research highlights the role of purinergic signaling through nucleotides such as ATP and noradrenergic signaling through molecules like norepinephrine in regulating vascular tone and blood pressure. Notably, his findings reveal that Pannexin1 (Panx1) contributes to vasoconstriction mediated by the α1 adrenoreceptor, particularly during periods of heightened sympathetic nervous activity. Additionally, he has developed methods for regulating leukocyte adhesion, demonstrating the involvement of Panx1 channels in promoting leukocyte adhesion and emigration during acute systemic inflammation.

Career Highlights

Brant E Isakson is affiliated with the University of Virginia, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential applications in treating conditions related to blood pressure regulation and inflammation.

Collaborations

Throughout his career, Isakson has collaborated with notable colleagues, including Marie Billaud and

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…